Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Hyperion Therapeutics receives orphan drug exclusivity from FDA
Yahoo/Fly on the Wall
Thursday, May 2, 2013 - 10:48am
tags:
FDA, Hyperion Therapeutics, orphan drugs, Ravicti
Glaxo Mined Online Parent Discussion Boards For Vaccine Worries
WSJ Online
Thursday, May 2, 2013 - 10:45am
tags:
GSK, vaccines, message boards, social media, text analytics
Lpath: The Leader In Lipidomics
Seeking Alpha
Thursday, May 2, 2013 - 10:43am
tags:
Lpath, monoclonal antibodies
A Sweeter Deal On The Horizon For Prolor Biotech?
Seeking Alpha
Thursday, May 2, 2013 - 10:42am
tags:
Prolor Biotech, OPKO Health
Takeda Gets $6.5 Million Diabetes-Drug Verdict Thrown Out
Bloomberg
Thursday, May 2, 2013 - 10:38am
tags:
diabetes, Takeda, Actos, bladder cancer
Novartis Unloads OTC Products Made At Troubled Nebraska Plant
Pharmalot
Thursday, May 2, 2013 - 10:37am
tags:
OTC, Novartis
[video]3 Biggest Biotech Crashes in April
Motley Fool
Thursday, May 2, 2013 - 10:36am
tags:
Dyax, Rigel Pharmaceuticals, Sarepta, AstraZeneca
Impax Laboratories Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Thursday, May 2, 2013 - 10:34am
tags:
Impax Laboratories, earnings
Big Pharma's Kickback Conundrum
Motley Fool
Thursday, May 2, 2013 - 10:33am
tags:
Pfizer, kickbacks, GSK, Novartis
Sanofi 1Q net drops 45 percent as generic competition slashes sales of Plavix, other drugs
Yahoo/AP
Thursday, May 2, 2013 - 10:31am
tags:
Sanofi, earnings
Genmab Rises After FDA Grants Breakthrough Status to Cancer Drug
Bloomberg
Thursday, May 2, 2013 - 10:31am
tags:
Genmab, FDA, JNJ, daratumumab, Multiple Myeloma
Shire cuts sales forecast as some drugs miss Q1 targets
Reuters
Thursday, May 2, 2013 - 10:29am
tags:
earnings, Shire
Regeneron Pharmaceuticals Earnings Preview: Can This Streak Continue?
Wall St. Cheat Sheet
Thursday, May 2, 2013 - 10:29am
tags:
earnings, Regeneron
Gilead combo hepatitis C pill shown effective in small trial
Reuters
Thursday, May 2, 2013 - 10:28am
tags:
hepatitis C, Gilead, ledipasvir, sofosbuvir
Gilead Sciences Earnings Preview: Get Ahead of the Analysts
Wall St. Cheat Sheet
Thursday, May 2, 2013 - 10:27am
tags:
earnings, Gilead
Allergan shares fall on delay of eye drug study
Yahoo/AP
Wednesday, May 1, 2013 - 4:05pm
tags:
Allergan, Eylea, Regeneron
Weak Quarter At Auxilium Overshadows Execution On Long-Term Strategy
Seeking Alpha
Wednesday, May 1, 2013 - 4:03pm
tags:
Auxilium, earnings
Allergan Evaluates Bids for its Lap-Band Weight Loss Product
Bloomberg
Wednesday, May 1, 2013 - 11:38am
tags:
Allergan, Lap-Band, M&A
Merck spotlights new deals, R&D review as demands to rebuild pipeline grow
Fierce Biotech
Wednesday, May 1, 2013 - 11:06am
tags:
Merck, R&D
Regeneron execs score $140M payday as Eylea mints money
Fierce Pharma
Wednesday, May 1, 2013 - 11:05am
tags:
Regeneron, Eylea, executive pay

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.